Stifel Financial Corp Increases Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Stifel Financial Corp increased its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 12.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 296,491 shares of the company's stock after acquiring an additional 33,567 shares during the quarter. Stifel Financial Corp owned about 0.06% of GE HealthCare Technologies worth $23,180,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors also recently bought and sold shares of GEHC. Capital Research Global Investors increased its stake in shares of GE HealthCare Technologies by 4.5% during the fourth quarter. Capital Research Global Investors now owns 60,832,004 shares of the company's stock valued at $4,755,851,000 after purchasing an additional 2,608,066 shares in the last quarter. Vanguard Group Inc. increased its position in GE HealthCare Technologies by 4.3% during the 4th quarter. Vanguard Group Inc. now owns 52,537,446 shares of the company's stock valued at $4,107,378,000 after buying an additional 2,155,429 shares in the last quarter. Geode Capital Management LLC raised its stake in GE HealthCare Technologies by 3.1% during the fourth quarter. Geode Capital Management LLC now owns 11,320,576 shares of the company's stock valued at $882,777,000 after buying an additional 342,819 shares during the last quarter. Invesco Ltd. boosted its holdings in GE HealthCare Technologies by 18.4% in the fourth quarter. Invesco Ltd. now owns 8,067,927 shares of the company's stock worth $630,751,000 after acquiring an additional 1,252,613 shares in the last quarter. Finally, Norges Bank purchased a new stake in shares of GE HealthCare Technologies in the fourth quarter worth $488,531,000. 82.06% of the stock is owned by hedge funds and other institutional investors.

GE HealthCare Technologies Stock Performance

NASDAQ GEHC traded up $2.86 on Wednesday, hitting $70.95. 4,600,639 shares of the company traded hands, compared to its average volume of 3,280,209. The business's 50 day moving average price is $75.62 and its 200-day moving average price is $81.81. The company has a market capitalization of $32.48 billion, a price-to-earnings ratio of 16.35, a P/E/G ratio of 3.19 and a beta of 1.14. The company has a current ratio of 1.04, a quick ratio of 0.83 and a debt-to-equity ratio of 0.88. GE HealthCare Technologies Inc. has a 52-week low of $57.65 and a 52-week high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its quarterly earnings data on Wednesday, April 30th. The company reported $1.01 EPS for the quarter, beating the consensus estimate of $0.91 by $0.10. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The business had revenue of $4.78 billion for the quarter, compared to the consensus estimate of $4.66 billion. During the same period in the previous year, the business earned $0.90 earnings per share. The business's revenue was up 2.7% on a year-over-year basis. Equities analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Shareholders of record on Friday, April 25th will be paid a $0.035 dividend. This represents a $0.14 annualized dividend and a yield of 0.20%. The ex-dividend date of this dividend is Friday, April 25th. GE HealthCare Technologies's payout ratio is currently 3.23%.

Analysts Set New Price Targets

A number of analysts have weighed in on the stock. BTIG Research set a $95.00 price objective on shares of GE HealthCare Technologies and gave the company a "buy" rating in a research note on Monday, April 14th. Citigroup raised their price target on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the company a "buy" rating in a research report on Thursday, February 13th. The Goldman Sachs Group raised GE HealthCare Technologies from a "neutral" rating to a "buy" rating and upped their price objective for the company from $85.00 to $100.00 in a research report on Tuesday, March 11th. Piper Sandler reduced their target price on GE HealthCare Technologies from $104.00 to $88.00 and set an "overweight" rating for the company in a report on Wednesday, April 23rd. Finally, Wells Fargo & Company increased their price objective on GE HealthCare Technologies from $96.00 to $103.00 and gave the company an "overweight" rating in a research report on Friday, February 14th. One investment analyst has rated the stock with a sell rating, two have given a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $96.50.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.